Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis Induction of Remission
Kate Farms Inc
36 participants
Mar 18, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to introduce a new dietary therapy for Eosinophilic Esophagitis (EoE) patients by using partial enteral nutrition (PEN) to enhance remission rates and explore how this approach affects immune function, gut microbiota, and environmental toxin exposures.
Eligibility
Inclusion Criteria1
- Pediatric patients 1 year to 21 of age presenting with chronic symptoms of dysphagia, odynophagia, vomiting or heartburn, chronic abdominal pain, weight loss, picky eating, to outpatient gastroenterology clinic and are planning to undergo EGD for evaluation.
Exclusion Criteria5
- Non-English-Speaking Subjects, adults unable to consent, wards of the state, pregnant women, and prisoners will be excluded from the study.
- Patients with autoimmune conditions such as inflammatory bowel disease. Patients with prior esophageal or intestinal surgeries.
- Patients with history of eating disorders or ARFID.
- Patients with fistulizing or fibrotic disease on baseline EGD.
- Patients who have received proton pump inhibitory therapy in the past month.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients in the PEN with dairy elimination group will receive 50% calories from Kate Farms Standard 1.2 formula and 50% dairy free regular diet.
Participants in this group will be on a dairy-free regular diet alone.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07234825